Guna MD-Muscle - Collagen pack of 10x2ml

MD-MUSCLE can be used independently or in combination with other medical devices from the same series, in order to adapt the treatment to the clinical situation.

If support of the connective tissue matrix is ​​necessary or when the physiological aging process is to be slowed down, MD-MUSCLE can be administered in combination with MD-MATRIX and MD-TISSUE.

The product can also be used as mechanical support in the treatment of the following diseases:

Pain treatment: acute, subacute, chronic

Treatment of the body area where referred pain occurs (in combination with MD-NEURAL)

Treatment of trigger points (in combination with MD-NEURAL)

Fibromyalgia syndrome (in combination with MD-NEURAL)

Dermatomyositis

The administration schedule may vary, depending on individual needs.

Treatment protocol: 2 treatments per week for the first 2 weeks; 1 treatment per week until symptoms alleviate (average 8-10 sessions). Treatment can be continued by performing 1 treatment per week, but no longer than for 10 weeks. In chronic pathological conditions, continue performing 1 treatment per week for a month, and then perform 1 treatment per month.

Intradermal and subcutaneous injection method: the injection site must be sterile; insert the needle to a depth of 1-3 mm and inject 0.2-0.3 ml of the preparation into the affected tissue.

Periarticular injection method: the injection site must be sterile; insert the needle near the joint to the required depth

For this purpose, it is recommended to use the following materials and devices:

Materials for aseptic preparation of the skin surface: sterile gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride skin spray

Needles: sterile 27 G, 4 mm

Syringes: size 5 or 10 ml, depending on the volume of the solution to be injected

Contraindications:

No cases of hypersensitivity to MD-MATRIX have been observed. However, patients with a known hypersensitivity to any of the ingredients of the preparation should undergo an allergy test prior to its use, consisting of a point injection of 0.1 ml of the preparation into the forearm or upper arm area, and then should be observed for 1 hour.

Slight redness at the injection site may result from the mechanical effect of the needle insertion or from a skin reaction.

Warnings and precautions:

The administration of the preparation may cause symptoms such as burning/pain at the injection site, which usually disappear spontaneously within 5-10 minutes after the procedure.

Cleaning and disinfection of the skin is necessary before and after the administration of the preparation. Saprophytic bacteria can cause an abscess to form at the injection site.

Expiration date and storage:

Protect from sunlight and freezing.

Storage and use conditions: 2-30°C

KEEP IN A PLACE OF OUT OF REACH OF CHILDREN.

Do not use after the expiry date. The expiry date refers to the product stored in correct conditions, in the original and undamaged packaging.

The product should be used immediately after opening.

Recommendation in case of damage to sterile vials:

Do not use if the seal is broken or if the vial is leaking.

The contents of the vial must be administered immediately after opening.

Do not use if the packaging is damaged.

The product must only be used by professionals and people with appropriate education or training.